Skip to main content
Sugentech, Inc. logo

Sugentech, Inc. — Investor Relations & Filings

Ticker · 253840 ISIN · KR7253840003 KO Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2024-02-28 Earnings Release
Country KR South Korea
Listing KO 253840

About Sugentech, Inc.

https://www.sugentech.com/en/

Sugentech, Inc. is an in-vitro diagnostics (IVD) company that develops and commercializes diagnostic solutions by integrating biotechnology, nanotechnology, and information technology. The company's product portfolio serves diverse healthcare settings, from large hospitals and laboratories to smaller clinics and home users. Key offerings include automated multi-immunoblot systems, point-of-care testing (POCT) platforms, and self-diagnostic kits for personal use, such as ovulation and pregnancy tests. Sugentech leverages proprietary technologies in developing high-level antibodies and advanced nanoparticles to create highly sensitive and precise immunochemical assays, underpinning its digital healthcare diagnostic platform for personalized medicine.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a significant change in revenue or profit/loss structure (30% or more). It provides a summary of financial performance (revenue, operating profit, net income) for the current and previous fiscal years, along with the reasons for the change. This is a standard regulatory disclosure for listed companies in Korea, which falls under the 'Earnings Release' category as it provides the initial announcement of financial results highlights. FY 2023
2024-02-28 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding the 'Acquisition of Convertible Bonds before Maturity' (전환사채 발행후 만기전 사채 취득). This is a specific corporate action related to capital structure and debt management. Since it details the repurchase of debt instruments (convertible bonds) by the company, it falls under the category of capital and financing updates.
2024-01-16 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the termination of a trust contract for the acquisition of treasury shares (자기주식취득 신탁계약 해지 결정). This relates to the company's own share management activities, specifically the termination of a share repurchase trust. According to the provided filing definitions, 'Transaction in Own Shares' (POS) is the appropriate category for reports of a company buying back or selling its own shares, including the termination of trust agreements related to such activities.
2023-12-28 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '신탁계약해지결과보고서' (Report on the Results of Termination of Trust Agreement) filed by Sugentech with the Financial Supervisory Service (FSS). It details the termination of a trust agreement used for share buybacks and the subsequent transfer of those shares to the company's own account. This falls under the category of 'Transaction in Own Shares' (POS) as it reports the final status of a share repurchase program.
2023-12-28 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the meeting preparation. Given the nature of the announcement and the lack of a specific category for 'Record Date/Shareholder Register' notices, it falls under the general regulatory filing category.
2023-12-15 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Sugentech Inc. covering the period from January 1, 2023, to September 30, 2023. It contains detailed financial information, business descriptions, and management disclosures required for a quarterly filing in Korea. It is not an announcement or a certification, but the full report itself, which fits the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.